Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$8.42 - $15.32 $4.7 Million - $8.54 Million
-557,669 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$14.59 - $23.26 $2.08 Million - $3.31 Million
-142,331 Reduced 20.33%
557,669 $8.42 Million
Q3 2021

Nov 12, 2021

BUY
$15.75 - $30.29 $11 Million - $21.2 Million
700,000 New
700,000 $16.7 Million

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $110M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Coatue Management LLC Portfolio

Follow Coatue Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coatue Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coatue Management LLC with notifications on news.